Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nectin cell adhesion molecule 1 (NECTIN1), also known as PVRL1 or CD111, is a calcium-independent cell-cell adhesion molecule belonging to the immunoglobulin superfamily, primarily located at adherens junctions in epithelial and neuronal tissues [12, 24]. It serves as the principal host cell receptor for the entry of Herpes Simplex Virus types 1 and 2 (HSV-1 and HSV-2) by binding with high affinity to the viral envelope protein Glycoprotein D (gD) [1, 18]. This interaction is a critical step in the viral life cycle, as it triggers the conformational changes in gD necessary to activate the core fusion machinery (gB and gH/gL), facilitating membrane fusion and viral entry [10, 11, 18]. Beyond its role as a viral portal, Nectin-1 is essential for normal tissue architecture and development; mutations in the NECTIN1 gene are linked to cleft lip and palate syndromes, and its dysregulation is associated with the progression and metastasis of various cancers, including hepatocellular carcinoma [21, 24]. Therapeutic efforts targeting the gD/Nectin-1 axis include the development of subunit and mRNA vaccines (e.g., gD2t-AS04, BNT163), neutralizing monoclonal antibodies, and peptidomimetics designed to block viral attachment and spread [2, 3, 6, 7].
Inhibition of viral entry by blocking the interaction between Herpes Simplex Virus Glycoprotein D and host Nectin receptors.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nectin cell adhesion molecule 1 (NECTIN1) (Nectin-1).